Nipro Brand Guidelines: From Light Bulbs in Otsu to Dialyzers in Odate

A light-bulb business, ampoule tubes and a supermarket.

Nipro did not start in medicine. The company’s own history says its founder, Sano Minoru, was just 20 when he started a light-bulb recycling business in Otsu, in Shiga Prefecture, in 1947, with help from a local gas company. In 1950 a small bulb works was set up in Otsu and began trading with the glass section of NEC, the electronics group.

The legal company dates from 8 July 1954, when Nihon Glass Shoji was established in Kyoto’s Shimogyo ward to sell glass tubes for ampoules and pill bottles. Nipro gives that day as its date of establishment, and English Wikipedia gives 1954 as its founding year. In 1959 the head office moved to Osaka, and a factory in Otsu began making glass bottles and small bulbs in 1960. By 1963 the company had developed machines to process the inner flasks of vacuum flasks, and it had also opened a supermarket, later called Nissho Store.

Medicine came through acquisition. In 1965, the company says, it began selling infusion kits to pharmaceutical companies; in 1969 it bought Tomisawa Manufacturing, now Nipro Medical Industries, and began producing medical devices; and in 1972 it bought Nihon Plastic Specialties, renamed it Nipro, and used it to sell devices in Japan. The parent itself took the name Nissho in 1977 and only became Nipro Corporation in 2001, when it merged with that sales company.

Dialyzers, sets and the Odate factory.

From the mid-1970s the focus was the artificial kidney. Nipro says it began making disposable syringes and coil dialyzers in 1974, then blood tubing, infusion kits and hollow-fibre dialyzers in 1975, and vacuum blood-collection tubes and catheters in 1976. It opened a technological development centre in Kusatsu, Shiga, in 1977 and a factory in Odate, Akita Prefecture, in 1981. In 1988 it developed a cellulose triacetate dialyzer and set up its first overseas manufacturing and sales base, in Thailand; a European company followed in Belgium in 1991 and an American one in 1996.

Much of that early growth came from supplying other firms. Nipro says it began supplying dialyzers and related products to a large American medical distributor in 1983, insulin injection needles to a large Danish pharmaceutical company in 1984, and arteriovenous fistula needles for dialysis to a Swedish device company in 1986. In the 1990s it moved into pre-filled and combined drug-and-device kits, developing an integrated antibiotic kit with a drug maker in 1990, its history says. Japanese Wikipedia adds that in 2015 it took over the medical business of Unitika, covering catheters, wound dressings, enzymes and diagnostic reagents.

The company describes three pillars — medical devices, pharmaceuticals and glass — and it built all three through purchases. It took a stake in Hishiyama Pharmaceutical, now Nipro Pharma, in 1988; bought the cardiopulmonary businesses of DIC in 2005 and of Edwards Lifesciences in 2006; bought Home Diagnostics, a diabetes testing company in the United States, in 2010; and bought medical-glass plants in France, Belgium and the US from Amcor in 2011, its history says. In February 2018 it made Machida, an endoscope maker, a subsidiary, English Wikipedia says. It also left retailing, selling the Nissho supermarket business to Hankyu Department Stores in 2006.

On production, Nipro says that since 2007 its Odate factory has run the whole chain from spinning hollow-fibre membranes to finished dialyzers. Its corporate overview lists factories at Odate, at Kusatsu near Lake Biwa and at Seto in Aichi, with research and a training facility for clinicians, NIPRO iMEP, at its life-science site in Kusatsu. Its dialysis range, as the company lists it, runs from dialyzers and blood tubing sets to single-use dialysis needles and indwelling catheters; its general devices include needleless infusion systems and implantable infusion ports.

Japanese Wikipedia records one design honour: a Good Design Award in 2005 for “Universal PTP,” a blister pack made by Nipro Pharma for an oral anticoagulant that Nipro co-marketed.

How the category presents itself.

Hospital device makers sell to clinicians, purchasing teams and hospital engineers rather than to shoppers, and their brands are built for that audience. Their catalogues and websites tend to show the equipment where it is used: infusion pumps on poles beside a bed, dialysis machines lined up in a treatment room, monitors and consoles in intensive care.

Much of the product is small and disposable, so the pictures often come close. Gloved hands hold a catheter, a cannula or an infusion set; blood tubing is coiled for a dialysis session; a dialyzer or a single-use endoscope is photographed on plain white so that every connector and label can be read. Product names usually lean on model numbers and technical terms rather than on lifestyle words.

People appear too, usually in uniform: nurses and doctors at the bedside, technicians at a workbench, trainers at a company teaching centre. Several makers in this group run their own training facilities for clinicians, and they present them as part of what they sell alongside the devices.

The trade meets at congresses and fairs. Medica in Düsseldorf gathers hospital suppliers from around the world each autumn; ASN Kidney Week, the American Society of Nephrology’s annual meeting, draws dialysis makers; and Digestive Disease Week brings together gastroenterologists and endoscopy suppliers. Stands, booth graphics and congress brochures are where many of these brands are seen at their largest, and this guide sets out what can be checked about each company: who founded it, who owns it, and where it says its products are made.

A Japanese group with a dialysis core.

Nipro remains an independent listed company, on the Prime Market of the Tokyo Stock Exchange. In April 2023 it moved its head office to a new building in Settsu, in Osaka Prefecture, inside the Kento Innovation Park, English Wikipedia says; the company’s overview now gives Settsu as its registered head office, with a Tokyo branch.

In the United States the group trades through Nipro Medical Corporation, a wholly owned subsidiary with offices in New Jersey and Florida. In March 2022 it announced the full commercial launch of the SURDIAL DX haemodialysis system in American clinics after a soft launch in late 2021; the release said the machine was manufactured in Japan, and that Nipro also had local manufacturing in Pennsylvania. A sister model has drawn regulatory attention: in February 2022 the UK’s Medicines and Healthcare products Regulatory Agency published device safety information on the Surdial X haemodialysis machine, made by Nipro, about fluid removal outside the machine’s specification, noting that the maker had already issued a field safety notice and was investigating.

For a design guide, Nipro shows how a company that began with glass and light bulbs can grow into a dialysis specialist while keeping glass as one of its businesses. Compare Terumo, another Japanese device maker, and Fresenius, a German name in dialysis. For this guide we use a deep blue, a glass teal and a pale mist with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep Nipro’s identity on hand — save it to a board in the Made Good inspiration library.